68382-751 : Temozolomide 5 mg Oral Capsule


NDC68382-751
Labeler: Zydus Pharmaceuticals (Usa) Inc.
Product Type: Human Prescription Drug
Drug Name:  Temozolomide
Dosage Form: Oral Capsule
Application #: ANDA206750
Rev. Date: 

NDC 68382-751 QR Code


Appearance:


Markings: 751
Shapes:  Capsule
Colors:  Green / White
Size (mm): 11
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 68382-751-67: 14 CAPSULE IN 1 BOTTLE (68382‑751‑67)
  • 68382-751-96: 5 CAPSULE IN 1 BOTTLE (68382‑751‑96)

Active Ingredients:

  • Temozolomide

Dosage Strength:

  • 5 mg

Inactive Ingredients:

  • Alcohol
  • Ammonia
  • Anhydrous Lactose
  • Butyl Alcohol
  • Fd&c Blue No. 1
  • Fd&c Red No. 3
  • Ferric Oxide Yellow
  • Ferrosoferric Oxide
  • Gelatin
  • Isopropyl Alcohol
  • Potassium Hydroxide
  • Propylene Glycol
  • Shellac
  • Silicon Dioxide
  • Sodium Lauryl Sulfate
  • Sodium Starch Glycolate Type B Potato
  • Stearic Acid
  • Tartaric Acid
  • Titanium Dioxide
  • Water

Pharmaceutical Classes:

  • Alkylating Activity [MoA]
  • Alkylating Drug [EPC]

Related Products:

Based on records with the same trade name.
  • 68382-752 Temozolomide 20 mg Oral Capsule by Zydus Pharmaceuticals (Usa) Inc.
  • 68382-753 Temozolomide 100 mg Oral Capsule by Zydus Pharmaceuticals (Usa) Inc.
  • 68382-754 Temozolomide 140 mg Oral Capsule by Zydus Pharmaceuticals (Usa) Inc.
  • 68382-755 Temozolomide 180 1/1 Oral Capsule by Zydus Pharmaceuticals (Usa) Inc.
  • 68382-756 Temozolomide 250 mg Oral Capsule by Zydus Pharmaceuticals (Usa) Inc.
  • 0054-0320 Temozolomide 5 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0054-0321 Temozolomide 20 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0054-0322 Temozolomide 100 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0054-0323 Temozolomide 140 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0054-0324 Temozolomide 180 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0054-0325 Temozolomide 250 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0093-7599 Temozolomide 5 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7600 Temozolomide 20 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7601 Temozolomide 100 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7602 Temozolomide 250 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7638 Temozolomide 140 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7639 Temozolomide 180 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0378-5260 Temozolomide 5 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-5261 Temozolomide 20 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-5262 Temozolomide 100 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • More related products ...
< Prev: 68382-750Next: 68382-752 >

Related Discussions:

Temozolomide
Please be as detailed as possible...




Notice: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2018 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 19 August 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.